OpenAlex

Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies

Cochrane Database of Systematic Reviews 5 (2018)

Ole Jakob Storebø; Nadia Billesborg Pedersen; Erica Ramstad; Maja Laerke Kielsholm; Signe Sofie Nielsen; Helle B. Krogh; Carlos Renato Moreira Maia; Frederik Løgstrup Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna M. Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja Jul Håkonsen; Lise Aagaard; Erik Hertel Simonsen; Christian Nyfeldt Gluud

Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis

European Child & Adolescent Psychiatry 27(10) (2018)

Suellen Camila Padilha; Suzane Virtuoso; Fernanda S. Tonin; Helena Hiemisch Lobo Borba; Roberto Pontarolo

Attention Deficit Hyperactivity Disorder in Preschool-Age Children

Child and Adolescent Psychiatric Clinics of North America 26(3) (2017)

Mini Tandon; Alba Pergjika

Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Aged Children

Journal of Child and Adolescent Psychopharmacology 28(9) (2018)

Ann Catherine Childress; Jeffrey G. Stark

Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review

Expert Opinion on Drug Safety 19(11) (2020)

Felice Iasevoli; Annarita Barone; Elisabetta Filomena Buonaguro; Licia Vellucci; Andrea de Bartolomeis

Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology 30(2) (2020)

Sharon B. Wigal; Phillip B. Chappell; Donna R. Palumbo; Shannon L. Lubaczewski; Sara Ramaker; Richat Abbas

Pharmacotherapy for Preschool Children with Attention Deficit Hyperactivity Disorder (ADHD): Current Status and Future Directions

CNS Drugs 35(4) (2021)

Jonathan R. Young; Adare Yanagihara; Rachel E. Dew; Scott Haden Kollins

Innovative therapeutic strategies using ADHD medications tailored to the behavioral characteristics of patients with chronic pain

Frontiers in Pharmacology 16 (2025)

Satoshi Kasahara; M. Takahashi; Takashi Suto; Taito Morita; Hideaki Obata; Shin‐ichi Niwa

Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed – Results from a randomized, double-blind, placebo-controlled clinical trial

Psychiatry Research 251 (2016)

Leila Jahangard; Shahrokh Akbarian; Mohammad Haghighi; Mohammad Ahmadpanah; Amir Keshavarzi; Hafez Bajoghli; Dena Sadeghi Bahmani; Edith Holsboer‐Trachsler; Serge Brand

Efficacy of stimulants for preschool attention‐deficit/hyperactivity disorder: A systematic review and meta‐analysis

JCPP Advances 3(3) (2023)

Luisa Shiguemi Sugaya; Luís C. Farhat; Pietro Califano; Guilherme V. Polanczyk

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder

Journal of Advanced Pharmaceutical Technology amp Research 7(4) (2016)

Ali Hasanpour Dehkordi; Parvin Safavi; Nasim Ghasemi

A systematic review of pharmacotherapy for attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders

Expert Opinion on Pharmacotherapy 24(13) (2023)

Arnaud Pouchon; Rayan Nasserdine; Clément Dondé; Antoine Bertrand; Mircea Polosan; Stéphanie Bioulac

The effect of metilpheniydate, risperidone and combination therapy on ECG in children with attention-deficit hyperactivity disorder

Journal of Electrocardiology 50(4) (2017)

Derya Karpuz; Olgu Hallıoğlu; Fevziye Toros; Bahar Taşdelen

Symptom scores and medication treatment patterns in children with ADHD versus autism

Psychiatry Research 288 (2020)

Susan Dickerson Mayes; James G. Waxmonsky; Raman K. Baweja; Richard E. Mattison; Hasan Memon; Melanie Klein; Usman Hameed; Daniel A. Waschbusch

Atypical antipsychotics for Attention-Deficit/Hyperactivity disorder- science, art, or fad?

European Psychiatry 62 (2019)

Ahmed Naguy; Mohamed S Hashem; Sulaiman AlKhadhar

A Comparative Study of Risperidone and Aripiprazole in Attention Deficit Hyperactivity Disorder in Children Under Six Years Old: A Randomized Double-Blind Study

Iranian Journal of Pediatrics 28(1) (2018)

Katayoon Razjouyan; Arash Danesh; Mojgan Khademi; Rozita Davari-Ashtiani; Simasadat Noorbakhsh

Cancellation of outpatient appointments in patients with attention-deficit/hyperactivity disorder

PLoS ONE 16(11) (2021)

健介 野村; Ryosuke Tarumi; Kazunari Yoshida; Mitsuhiro Sado; Takefumi Suzuki; Masaru Mimura; Hiroyuki Uchida

EFFICACY OF ARIPIPRAZOLE AND RISPERIDONE IN TREATMENT OF CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: A DOUBLE-BLIND CLINICAL TRIAL STUDY

Bulletin of Pharmaceutical Sciences Assiut 45(1) (2022)

Firoozeh Dreakhshanpour; Anahita Deylamsalehi; Seyed Moghadda; Najmeh Shahini

ADHD-A Clinician’s Bird’s Eye View of Current Status and New Vistas!

Psychopharmacology Bulletin 53(1) (2025)

Ahmed Naguy; SAXBY A. PRIDMORE; Salem Alwetayan; Dalal H. Elsori; Bibi Alamiri

The prevalance of attention deficit hyperactivity disorder and the frequency of medication use among preschool children in a district children hospital

Journal of Dr Behcet Uz Children s Hospital (2017)

Ayşe Kutlu; Nagihan Cevher Binici

Pharmacotherapy of attention-deficit hyperactivity disorder: common quandaries, dilemmas and challenges

International Clinical Psychopharmacology 35(6) (2020)

Mariela Mosheva; Nina Dar; Lee Rima Madi; Abraham Weizman; Doron Gothelf

DAT1 Gene Polymorphism in Children with Attention Deficit Hyperactivity Disorder

Iranian Journal of Pediatrics 28(3) (2018)

Seyed Mahmoud Tabatabaei; Shahrokh Amiri; Nasrin Forghani; Seyed Gholamreza Noorazar; Shahin Abdollahi Fakhim; Habibeh Barzegar; Mir Mahmoud Mirnasab

Psychopharmacology: Special Considerations When Working with Young Children

Pediatric school psychology (2019)

Justin A. Barterian

Okul Öncesi Dönemde Psikiyatrik Ilaç Tedavisi Başlanan Hastaların Ilaç Tedavisinden Fayda Görmeleri ve Yan Etkiler Açısından Retrospektif Taranması

Turkish Journal of Pediatric Disease 15(4) (2021)

Dilek Ünal; Kevser Nalbant; Dilek Ünal; Mine Aybı

11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology

Psychiatry and Clinical Psychopharmacology 29(sup1) (2019)

Dikkat Eksikliği ve Hiperaktivite Bozukluğu ile İlgili Her Şey

Akademisyen Kitabevi eBooks (2022)

Gülen Güler Aksu; Mutlu Muhammed Özbek; Hatice Aksu; Cem Gökçen; Fatma Subaşı Turğut; Ali Evren Tufan; Hicran Doğru; Onur Burak Dursun; Emre Özdemir; Fethiye Kılıçaslan; Meryem Özlem Kütük; Özge Metin; Pelin Dağ; Özhan Yalçın; Öznur Bılaç; Ozan Kayar; Halil Kara; Şeyma Gürbüz; Elvan İşeri; Seher Akbaş; İbrahim Durukan; Güneş Turhan; Hasan Kandemır; Müslüm Kul; Mustafa Tolga Tunagür; Börte Gürbüz Özgür; Özlem Özcan; Didem Behice Öztop; Burcu Akın Sarı; Ümit Işık; Derya Karpuz; Hande Ayraler Taner; Ender Atabay

Psychopharmacology Considerations for Children Aged under 6 Years

Child and Adolescent Psychiatric Clinics of North America 34(2) (2025)

Magdalena Romanowicz; Eric R. Pease; Idil Tarikogullari; NATALIE C. PON; Mary Margaret Gleason

Risperidone for children with attention-deficit/hyperactivity disorder and severe behavioral dysregulation: a randomized placebo-controlled assessor-blinded trial

BMC Psychiatry 26(1) (2026)

Ezatollah Abbasi; Alireza Abdi; Rana Eskandari